Inhibition of pulmonary artery smooth muscle cells via the delivery of curcuminoid WZ35 by Cu‐based metal organic frameworks
IET Nanobiotechnology · 2023-07 · 17 (5) · 420-424
DOI: 10.1049/nbt2.12138 ↗Kurz gefasst
Fachartikel in der Zeitschrift IET Nanobiotechnology, online erschienen am 16.05.2023. Verfasst von Zhidan Hua und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Z…. Hauptthemen laut MEDLINE: Curcumin, Metal-Organic Frameworks. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Health Commission, Wenzhou Municipal Science and Technology Bureau project.
Abstract (Originalsprache)
Hypoxic pulmonary hypertension (HPH) is a life‐threatening disease that occurs due to a lack of oxygen in the lungs, leading to an increase in pulmonary vascular resistance, right ventricular failure, and ultimately death. HPH is a multifactorial disorder that involves multiple molecular pathways, making it a challenge for clinicians to identify effective therapies. Pulmonary artery smooth muscle cells (PASMCs) play a crucial role in HPH pathogenesis by proliferating, resisting apoptosis, and promoting vascular remodelling. Curcumin, a natural polyphenolic compound, has shown potential as a therapeutic agent for HPH by reducing pulmonary vascular resistance, inhibiting vascular remodelling, and promoting apoptosis of PASMCs. Regulation of PASMCs could significantly inhibits HPH. However, curcumin has the disadvantages of poor solubility and low bioavailability, and its derivative WZ35 has better biosafety. Here, Cu‐based metal organic frameworks (MOF Cu ) was fabricated to encapsulate the curcumin analogue WZ35 (MOF Cu @WZ35) for the inhibition of PASMCs proliferation. The authors found that the MOF Cu @WZ35 could promote the death of PASMCs. Furthermore, the authors believed that this drug delivery system will effectively alleviate the HPH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Pulmonary and Critical Care Medicine, The Longgang People's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China.
- Department of Pulmonary and Critical Care Medicine, Ruian People's Hospital, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
ORCID-Profile: Mayun Chen
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Provincial Health Commission
- Wenzhou Municipal Science and Technology Bureau project
- Research Business Fund Project of Wenzhou Medical University
Zitieren
APA
Hua, Z., Han, M., Song, L., Yan, Y., Chen, H., Wang, J., Li, C., Chen, Y., Yan, H., & Chen, M. (2023). Inhibition of pulmonary artery smooth muscle cells via the delivery of curcuminoid WZ35 by Cu‐based metal organic frameworks. IET Nanobiotechnology, 17(5), 420-424. https://doi.org/10.1049/nbt2.12138
Vancouver
Hua Z, Han M, Song L, Yan Y, Chen H, Wang J, et al. Inhibition of pulmonary artery smooth muscle cells via the delivery of curcuminoid WZ35 by Cu‐based metal organic frameworks. IET Nanobiotechnology. 2023;17(5):420-424. doi:10.1049/nbt2.12138
BibTeX
@article{Hua2023,
author = {Hua, Zhidan and Han, Mingming and Song, Lanlan and Yan, Yongle and Chen, Honglang and Wang, Jilong and Li, Chao and Chen, Yanfan and Yan, Hanhan and Chen, Mayun},
title = {Inhibition of pulmonary artery smooth muscle cells via the delivery of curcuminoid WZ35 by Cu‐based metal organic frameworks},
journal = {IET Nanobiotechnology},
year = {2023},
volume = {17},
number = {5},
pages = {420--424},
doi = {10.1049/nbt2.12138}
}
EUVIMED